Dopamine receptor subtypes contribution to Homer1a induction: Insights into antipsychotic molecular action

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 5, 2009, Pages 813-821

  Iasevoli, Felice ^a   Tomasetti, Carmine ^a   Ambesi Impiombato, Alberto ^a   Muscettola, Giovanni ^a   de Bartolomeis, Andrea ^a  

^a Section of Psychiatry   (Italy)

Author keywords

Glutamate; Immediate early genes; PSD; Psychosis; Schizophrenia; Synaptic plasticity

Indexed keywords

2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; 3 [4 (4 CHLOROPHENYL 4 HYDROXYPIPERIDINO)METHYL]INDOLE; 3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; L 741626; METABOTROPIC RECEPTOR; PROTEIN HOMER 1A; PROTEIN HOMER 1B; TERGURIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; GENE EXPRESSION; GENETIC ANALYSIS; HIPPOCAMPUS; MALE; NERVE CELL PLASTICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PUTAMEN; RAT; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; CARRIER PROTEINS; DOPAMINE ANTAGONISTS; GENE EXPRESSION REGULATION; MALE; PROTEIN SUBUNITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE;

EID: 67649195722     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.02.009     Document Type: Article

References (66)

1. Ambesi-Impiombato A., D'Urso G., Muscettola G., and de Bartolomeis A. Method for quantitative in situ hybridization histochemistry and image analysis applied for Homer1a gene expression in rat brain. Brain Res Brain Res Protoc 11 (2003) 189-196
2. Ambesi-Impiombato A., Panariello F., Dell'Aversano C., Tomasetti C., Muscettola G., and De Bartolomeis A. Differential expression of Homer 1 gene by acute and chronic administration of antipsychotics and dopamine transporter inhibitors in the rat forebrain. Synapse 61 (2007)
3. Arnt J., and Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18 (1998) 63-101
4. Ary A.W., and Szumlinski K.K. Regional differences in the effects of withdrawal from repeated cocaine upon Homer and glutamate receptor expression: a two-species comparison. Brain Res 1184 (2007) 295-305
5. Audinot V., Newman-Tancredi A., Gobert A., Rivet J.M., Brocco M., Lejeune F., et al. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. J Pharmacol Exp Ther 287 (1998) 187-197
6. Beazely M.A., Tong A., Wei W.L., Van Tol H., Sidhu B., and MacDonald J.F. D2-class dopamine receptor inhibition of NMDA currents in prefrontal cortical neurons is platelet-derived growth factor receptor-dependent. J Neurochem 98 (2006) 1657-1663
7. Bottai D., Guzowski J.F., Schwarz M.K., Kang S.H., Xiao B., Lanahan A., et al. Synaptic activity-induced conversion of intronic to exonic sequence in Homer 1 immediate early gene expression. J Neurosci 22 (2002) 167-175
8. Bristow L.J., Cook G.P., Patel S., Curtis N., Mawer I., and Kulagowski J.J. Discriminative stimulus properties of the putative dopamine D3 receptor agonist, (+)-PD 128907: role of presynaptic dopamine D2 autoreceptors. Neuropharmacology 37 (1998) 793-802
9. Chaperon F., Tricklebank M.D., Unger L., and Neijt H.C. Evidence for regulation of body temperature in rats by dopamine D2 receptor and possible influence of D1 but not D3 and D4 receptors. Neuropharmacology 44 (2003) 1047-1053
10. Clifford J.J., and Waddington J.L. Topographically based search for an "Ethogram" among a series of novel D(4) dopamine receptor agonists and antagonists. Neuropsychopharmacology 22 (2000) 538-544
11. Costanza R.M., and Terry P. The dopamine D4 receptor antagonist L-745,870: effects in rats discriminating cocaine from saline. Eur J Pharmacol 345 (1998) 129-132
12. de Bartolomeis A., and Iasevoli F. The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapy. Psychopharmacol Bull 37 (2003) 51-83
13. Ekelund J., Slifstein M., Narendran R., Guillin O., Belani H., Guo N.N., et al. In vivo DA D(1) receptor selectivity of NNC 112 and SCH 23390. Mol Imaging Biol 9 (2007) 117-125
14. Freedman J.E., Waszczak B.L., Cox R.F., Liu J.C., and Greif G.J. The dopamine D3 receptor and 7-OH-DPAT. Trends Pharmacol Sci 15 (1994) 173-174
15. Hall H., Sedvall G., Magnusson O., Kopp J., Halldin C., and Farde L. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 11 (1994) 245-256
16. Harvey J., and Lacey M.G. A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. J Neurosci 17 (1997) 5271-5280
17. Heidinger V., Manzerra P., Wang X.Q., Strasser U., Yu S.P., Choi D.W., et al. Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: mediation through the Pyk2/Src-family kinase pathway in cortical neurons. J Neurosci 22 (2002) 5452-5461
18. Kalivas P.W., and Duffy P. Dopamine regulation of extracellular glutamate in the nucleus accumbens. Brain Res 761 (1997) 173-177
19. Kammermeier P.J. Endogenous homer proteins regulate metabotropic glutamate receptor signaling in neurons. J Neurosci 28 (2008) 8560-8567
20. Kammermeier P.J., and Worley P.F. Homer 1a uncouples metabotropic glutamate receptor 5 from postsynaptic effectors. Proc Natl Acad Sci U S A 104 (2007) 6055-6060
21. Kapur S., and Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: a new hypothesis. Am J Psychiatry 158 (2001) 360-369
22. Kato A., Ozawa F., Saitoh Y., Hirai K., and Inokuchi K. vesl, a gene encoding VASP/Ena family related protein, is upregulated during seizure, long-term potentiation and synaptogenesis. FEBS Lett 412 (1997) 183-189
23. Krivoy A., Fischel T., and Weizman A. The possible involvement of metabotropic glutamate receptors in schizophrenia. Eur Neuropsychopharmacol 18 (2008) 395-405
24. Kulagowski J.J., Broughton H.B., Curtis N.R., Mawer I.M., Ridgill M.P., Baker R., et al. 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor. J Med Chem 39 (1996) 1941-1942
25. LaHoste G.J., Henry B.L., and Marshall J.F. Dopamine D1 receptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials. J Neurosci 20 (2000) 6666-6671
26. Lewis D.A., and Lieberman J.A. Catching up on schizophrenia: natural history and neurobiology. Neuron 28 (2000) 325-334
27. Lima V.C., Molchanov M.L., Aguiar D.C., Campos A.C., and Guimaraes F.S. Modulation of defensive responses and anxiety-like behaviors by group I metabotropic glutamate receptors located in the dorsolateral periaqueductal gray. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 178-185
28. Mao L., Yang L., Tang Q., Samdani S., Zhang G., and Wang J.Q. The scaffold protein Homer1b/c links metabotropic glutamate receptor 5 to extracellular signal-regulated protein kinase cascades in neurons. J Neurosci 25 (2005) 2741-2752
29. Marcus M.M., Jardemark K.E., Wadenberg M.L., Langlois X., Hertel P., and Svensson T.H. Combined alpha2 and D2/3 receptor blockade enhances cortical glutamatergic transmission and reverses cognitive impairment in the rat. Int J Neuropsychopharmacol 8 (2005) 315-327
30. Millan M.J., Girardon S., Monneyron S., and Dekeyne A. Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D3 versus D2 receptors. Neuropharmacology 39 (2000) 586-598
31. Millan M.J., Gobert A., Newman-Tancredi A., Lejeune F., Cussac D., Rivet J.M., et al. S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626. J Pharmacol Exp Ther 293 (2000) 1048-1062
32. Millan M.J., Newman-Tancredi A., Quentric Y., and Cussac D. The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors. Psychopharmacology (Berl) 156 (2001) 58-62
33. Nichols C.D., Garcia E.E., and Sanders-Bush E. Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration. Brain Res Mol Brain Res 111 (2003) 182-188
34. Nicola S.M., and Malenka R.C. Modulation of synaptic transmission by dopamine and norepinephrine in ventral but not dorsal striatum. J Neurophysiol 79 (1998) 1768-1776
35. Norton N., Williams H.J., Williams N.M., Spurlock G., Zammit S., Jones G., et al. Mutation screening of the Homer gene family and association analysis in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 120 (2003) 18-21
36. Olney J.W., Newcomer J.W., and Farber N.B. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33 (1999) 523-533
37. Patel S., Freedman S., Chapman K.L., Emms F., Fletcher A.E., Knowles M., et al. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor. J Pharmacol Exp Ther 283 (1997) 636-647
38. Patel S., Chapman K.L., Marston D., Hutson P.H., and Ragan C.I. Pharmacological and functional characterisation of dopamine D4 receptors in the rat retina. Neuropharmacology 44 (2003) 1038-1046
39. Paxinos G., and Watson C. The rat brain stereotaxic coordinates (1997), Academic Press
40. Polese D., de Serpis A.A., Ambesi-Impiombato A., Muscettola G., and de Bartolomeis A. Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of d-cycloserine. Neuropsychopharmacology 27 (2002) 906-913
41. Potschka H., Krupp E., Ebert U., Gumbel C., Leichtlein C., Lorch B., et al. Kindling-induced overexpression of Homer 1A and its functional implications for epileptogenesis. Eur J Neurosci 16 (2002) 2157-2165
42. Robertson G.S., Matsumura H., and Fibiger H.C. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther 271 (1994) 1058-1066
43. Sala C., Roussignol G., Meldolesi J., and Fagni L. Key role of the postsynaptic density scaffold proteins Shank and Homer in the functional architecture of Ca2+ homeostasis at dendritic spines in hippocampal neurons. J Neurosci 25 (2005) 4587-4592
44. Serretti A., De Ronchi D., Lorenzi C., and Berardi D. New antipsychotics and schizophrenia: a review on efficacy and side effects. Curr Med Chem 11 (2004) 343-358
45. Sheng M., and Hoogenraad C.C. The postsynaptic architecture of excitatory synapses: a more quantitative view. Annu Rev Biochem 76 (2007) 823-847
46. Shiraishi-Yamaguchi Y., and Furuichi T. The Homer family proteins. Genome Biol 8 (2007) 206
47. Steiner H., and Gerfen C.R. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J Neurosci 13 (1993) 5066-5081
48. Sunahara R.K., Guan H.C., O'Dowd B.F., Seeman P., Laurier L.G., Ng G., et al. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 350 (1991) 614-619
49. Surmeier D.J., Ding J., Day M., Wang Z., and Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 30 (2007) 228-235
50. Szumlinski K.K., Kalivas P.W., and Worley P.F. Homer proteins: implications for neuropsychiatric disorders. Curr Opin Neurobiol 16 (2006) 251-257
51. Szumlinski K.K., Lominac K.D., Kleschen M.J., Oleson E.B., Dehoff M.H., Schwarz M.K., et al. Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes Brain Behav 4 (2005) 273-288
52. Toro C., and Deakin J.F. NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder. Schizophr Res 80 (2005) 323-330
53. Tseng K.Y., and O'Donnell P. D2 dopamine receptors recruit a GABA component for their attenuation of excitatory synaptic transmission in the adult rat prefrontal cortex. Synapse 61 (2007) 843-850
54. Ueta Y., Yamamoto R., Sugiura S., Inokuchi K., and Kato N. Homer 1a suppresses neocortex long-term depression in a cortical layer-specific manner. J Neurophysiol 99 (2008) 950-957
55. Van Tol H.H., Bunzow J.R., Guan H.C., Sunahara R.K., Seeman P., Niznik H.B., et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350 (1991) 610-614
56. Waters N., Svensson K., Haadsma-Svensson S.R., Smith M.W., and Carlsson A. The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm Gen Sect 94 (1993) 11-19
57. Westerink B.H., De Boer P., Timmerman W., and De Vries J.B. In vivo evidence for the existence of autoreceptors on dopaminergic, serotonergic, and cholinergic neurons in the brain. Ann N Y Acad Sci 604 (1990) 492-504
58. Wirkner K., Krause T., Koles L., Thummler S., Al-Khrasani M., and Illes P. D1 but not D2 dopamine receptors or adrenoceptors mediate dopamine-induced potentiation of N-methyl-d-aspartate currents in the rat prefrontal cortex. Neurosci Lett 372 (2004) 89-93
59. Wirtshafter D. Rotation and immediate-early gene expression in rats treated with the atypical D1 dopamine agonist SKF 83822. Pharmacol Biochem Behav 86 (2007) 505-510
60. Yamada S., Harano M., Annoh N., and Tanaka M. Dopamine D(3) receptors modulate evoked dopamine release from slices of rat nucleus accumbens via muscarinic receptors, but not from the striatum. J Pharmacol Exp Ther 291 (1999) 994-998
61. Yamada H., Kuroki T., Nakahara T., Hashimoto K., Tsutsumi T., Hirano M., et al. The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens. Brain Res 1131 (2007) 88-96
62. Yamamoto K., Sakagami Y., Sugiura S., Inokuchi K., Shimohama S., and Kato N. Homer 1a enhances spike-induced calcium influx via L-type calcium channels in neocortex pyramidal cells. Eur J Neurosci 22 (2005) 1338-1348
63. Yano M., Beverley J.A., and Steiner H. Inhibition of methylphenidate-induced gene expression in the striatum by local blockade of D1 dopamine receptors: interhemispheric effects. Neuroscience 140 (2006) 699-709
64. Yano M., and Steiner H. Methylphenidate (Ritalin) induces Homer 1a and zif 268 expression in specific corticostriatal circuits. Neuroscience 132 (2005) 855-865
65. Yuen E.Y., Jiang Q., Chen P., Feng J., and Yan Z. Activation of 5-HT2A/C receptors counteracts 5-HT1A regulation of n-methyl-d-aspartate receptor channels in pyramidal neurons of prefrontal cortex. J Biol Chem 283 (2008) 17194-17204
66. Zhang G., Mao L., Liu X., Parelkar N., Arora A., Yang L., et al. In vivo regulation of Homer1a expression in the striatum by cocaine. Mol Pharmacol 71 4 (2007) 1148-1158